Company intelligence / Profile preview

Hertility Health

London, England, United Kingdomhertilityhealth.com ↗

Ownership: Private
Development stage: Commercial

Overview

Hertility Health offers commercial at-home hormone and fertility diagnostic tests for women, with over 500,000 users. The company provides personalized care plans based on clinical-grade results and virtual consultations with reproductive specialists. It has built the world’s largest dataset on female reproductive health to drive evidence-based care solutions.

Therapeutic areas: EndocrinologyWomen's Health
Modalities: Device (diagnostic testing kit)Non-pharmacological therapy (consultation, counseling)
Industry: Protein Biomarker Diagnostics

Partnerships

Collaborations with nationwide clinics for ultrasound scans and egg freezing referralsBacked by top-rated research bodies for scientific guidance

Beyond the preview

Go deeper on Hertility Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hertility Health.

Explore the full profile